Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssociation HGE CHU Bordeaux Sud

About this trial

The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.

Eligibility criteria

Qualifiers

chronic hepatitis C

chronic hepatitis B

alcohol liver disease

non alcoholic liver disease

Disqualifiers

ascitis

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

10,000 Participants
are grouped into 1 trial group